First canine ehrlichiosis vaccine developed in Israel

01/2/2013 | Israel21c

Veterinary researchers in Israel have developed the first ever vaccine for canine monocytic ehrlichiosis, a potentially deadly tick-borne disease that affects dogs. Although more research is needed to ensure the vaccine protects against other strains, a commercial vaccine will likely be developed.

View Full Article in:

Israel21c

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR